Personnel Moves Archives - Page 3 of 42

QuidelOrtho terminates CEO

QuidelOrtho’s interim CEO Michael Iskra (left) and interim president Robert Bujarsku (right). [Image courtesy of QuidelOrtho]QuidelOrtho announced today that it terminated President and CEO Douglas Bryant, effective immediately.

The company said the decision came after a “comprehensive evaluation.” Bryant also resigned from the board of directors, effective today.

QuidelOrtho’s board formed the Office of the Chief Executive Officer on February 17 to ensure business continuity and effective leadership. The Office of the CEO is led by EVP and Chief Commercial Officer Michael Iskra, EVP and Chief Operating Officer Robert Bujarski and CFO Joseph Busky.

Iskra was appointed interim CEO and Bujarski interim president, both effective today. The pair will continue to fulfill their current responsibilities while assuming additional duties in their interim roles.

“Now is the time for a change in leadership that can accelerate our initiat…

A Medtronic EVP is leaving amid latest reorganization

Bob White [Image courtesy of Medtronic]Bob White, the EVP and president of Medtronic’s Medical Surgical portfolio, will be leaving the company due to a new round of reorganization.

CEO Geoff Martha announced that White was leaving at the end of the company’s Q3 earnings call this morning. Martha explained plans to end Medtronic’s ventilator business and combine what remains of Patient Monitoring and Respiratory Interventions into one business unit called Acute Care and Monitoring (ACM).

“He’s been such an impactful and important leader for the company for a long time, Martha said of White. “While the friendship will remain strong, we’re definitely going to miss working with him day to day. I want to wish him well. And know this comes from the board of directors and the executive committee and everybody at Medtronic who’s interacted with Bob — just a high ethical leader and just a good guy, and we wish him well.”…

CMR Surgical picks J&J veteran to lead efforts in Asia, Middle East, Africa

New CMR Surgical President and CCO for Asia Pacific, the Middle East and Africa, Sushobhan Dasgupta. [Image from Sushobhan Dasgupta on LinkedIn]CMR Surgical announced that it appointed Sushobhan Dasgupta as president and CCO for Asia Pacific, the Middle East and Africa.

Dasgupta offers more than 30 years of experience across diverse medtech markets globally. Notably, he spent three decades with Johnson & Johnson MedTech. Now, the veteran of the industry — and the region — comes to CMR to help drive operations around its surgical robot in the region.

Most recently, Dasgupta served as vice chair and global president at Shalby Limited, a healthcare group in India. There, he had responsibility for driving Shalby’s acquired orthopedic implant business, based in California. He also provided strategic oversight to the company’s base hospital business.

Dasgupta’s 30-year tenure at J&J MedTech included stints as a member of the J&J Orth…

High-ranking official in FDA’s CDRH plans to retire

Dr. William Maisel plans to retire this spring. [Image from the FDA website]Dr. William Maisel, Director of the Office of Product Evaluation and Quality (OPEQ) for the FDA Center for Devices and Radiological Health (CDRH) plans to retire this year.

MedTech Dive first reported the news on Feb. 15. An FDA spokesperson confirmed Maisel’s planned retirement via email. He spent more than 14 years with CDRH, including more than five years as director of OPEQ.

According to the spokesperson, Maisel plans to retire in the spring. CDRH plans to conduct a national search to fill his position.

In the interim, the FDA plans for Dr. Owen Faris to serve in an acting capacity as director of OPEQ. Faris currently serves as principal deputy director of Opeq and has spent more than two decades at the FDA. His previous roles include director of the Office of Clinical Evidence and Analysis and the clinical trials director, in addition to his current role in OPEQ.

O…

Medtronic names first chief sustainability officer

New Medtronic Chief Sustainability Officer Raman Venkatesh brings experience in sustainability efforts to the medtech giant. [Image courtesy of Ken Washington on LinkedIn]A Medtronic (NYSE: MDT) + executive shared on social media that the company named a chief sustainability officer.

Raman Venkatesh will join the medtech giant as VP and CSO — a newly created role — starting on Feb. 19. Ken Washington, Medtronic SVP and chief technology officer, announced the appointment on LinkedIn.

In the role, Venkatesh holds responsibility for leading the development and execution of the company’s environmental sustainability strategy.

“I am excited to see Raman and his team drive Medtronic forward on our sustainability journey,” Washington posted. “I am confident that together we will shape and unlock new innovative solutions that serve our patients and our planet.

Venkatesh’s career history…

Accelus adds duo of directors to its board

Bernie Haffey (left) and Kevin McGann (right). [Images courtesy of Accelus]Spine implant developer Accelus announced today that it appointed Kevin McGann and Bernie Haffey to its board of directors.

The Palm Beach Gardens, Florida-based company said the new appointments provide a strategic enhancement and align with its mission. Accelus aims to deliver innovative spinal solutions that elevate the surgical experience and improve patient outcomes. It raised $20 million to support that expandable spine implant technology just last month.

McGann currently serves as president and CEO at Accelus, a role he first took up in April 2023. He originally joined the company in 2019 and served in roles including the post of chief commercial officer. McGann brings extensive experience in the spine industry, with previous positions including the role of VP of sales at Stryker.

Additionally, McGann served as VP of U.S. sales for Medtronic Spine & Biologics and area dire…

Enable Injections promotes COO from within

David Kroekel. [Image courtesy of Enable Injections]Wearable drug delivery technology maker Enable Injections announced today that it named David Kroekel as its new COO.

Cincinnati-based Enable develops the enFuse platform, whichallows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use. The FDA cleared the system for the delivery of Empaveli in October.

Get the full story at our sister site, Drug Delivery Business News.

Former Tandem CCO joins Ascensia as president of CGM

Ascensia Diabetes Care parent company PHC Holdings and Senseonics announced today that Ascensia named Brian Hansen its president of CGM.

Hansen’s appointment to the newly created role at the global distributor of Senseonics’ Eversense CGM went into effect today, Feb. 6.

Responsibilities for Hansen include the global commercialization and growth of the Eversense system. The fully implantable CGM allows for the continuous measurement of glucose levels for up to six months. With longevity, it also offers features like a removable transmitter, discreet on-body vibe alerts, accuracy and a smartphone app.

Hansen previously served as chief commercial officer at insulin pump maker Tandem Diabetes Care.

Get the full story at our sister site, Drug Delivery Business News.

Globus Medical promotes new COO from within

Keith Pfeil. [Image courtesy of Globus Medical]Globus Medical (NYSE: GMED) + announced that it promoted CFO Keith Pfeil to the position of chief operating officer (COO).

Pfeil first took over the CFO post in August 2019. Globus Medical hopes his new expanded role can help further drive its strategic roadmap through business and operational planning in addition to financial performance management.

He continues reporting to Globus President and CEO Dan Scavilla.

“I am excited to take on the role of COO in addition to my current role of CFO, as Globus continues to build on the momentum we have created to transform our industry and help change more patient lives around the globe,” said Pfeil. “I look forward to continuing to work with our board of directors, Dan and the executive leadership team to further realize our growth potential.”

His responsibilities include overseeing all day-to-d…

LivaNova picks longtime J&J exec as new CEO

New LivaNova CEO Vladimir Makatsaria. [Image from LinkedIn]LivaNova (Nasdaq: LIVN) + announced today that its board of directors appointed Vladimir A. Makatsaria as its CEO and a member of the board.

The appointment goes into effect on March 1, 2024. He succeeds Bill Kozy, who took over the CEO role on an interim basis in April 2023 when Damien McDonald resigned from the corner office.

Makatsaria most recently served as company group chair at Johnson & Johnson MedTech. He took up that position in October 2018 to lead the company’s global Ethicon surgery business. Overall, he spent more than 27 years at the medtech giant, including stints as the company’s group chair for medical devices in Asia Pacific and as the J&J chair for China.

“Vlad is a respected leader in the medical device industry with a proven reputation for delivering results, driving innovation and building great teams,” said Bill K…

Inspire Medical CEO takes over as board chair

Inspire Medical Systems (NYSE:INSP) announced today that Marilyn Carlson Nelson retired as chair of the company’s board of directors.

The Minneapolis-based sleep apnea treatment developer appointed current CEO Timothy Herbert to the additional role of board chair. Herbert’s appointment goes into effect after the company’s annual meeting of stockholders on May 2, 2024.

Nelson became the chair of the Inspire board in 2018 following the passing of her husband. Dr. Glen D. Nelson had been the company’s original board chair.

Herbert, the founder of Inspire, has held the post of president and CEO since May 2007. He brings decades of expertise in the medical device industry.

“Marilyn has had a profound impact on our business and our employees through her many years on the board,” Herbert said in a news release. “I want to personally thank Marilyn for her leadership and mentoring not only myself but the entire team ove…

Boston Scientific picks new investor relations VP, chief accounting officer

Boston Scientific (NYSE: BSX) + announced that it appointed a new SVP of investor relations and a new chief accounting officer.

In an SEC filing, the company announced the appointments, made on Jan. 26. Jonathan Monson takes over as SVP, investor relations, effective March 1, 2024. Monson currently serves as SVP, global controller and chief accounting officer, positions he took up in July 2019.

With Monson departing those roles, Boston Scientific chose Emily Woodworth as SVP, global controller and chief accounting officer. Woodworth takes over on March 1 as well. She currently serves as VP of finance and controller of the company’s Urology unit, having also taken on those posts in July 2019.

Before her current role, Woodworth was director of global technical accounting and external reporting from April 2016 until July 2019. Prior to that, she served as controller and finance director for Boston Scientific&…